CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 305 enrolled
Drug / intervention
Intervention group +1 morebehavioral
Likely dose
Not stated in record
Key inclusion· 6
  • Age 18 years or older
  • Confirmed HIV-positive diagnosis
  • Undetectable HIV viral load (< 200 copies/mL) within past 18 months
  • Hypertension with average systolic BP ≥130 and/or diastolic ≥90 mmHg on most recent 4 outpatient measurements in past 18 months
Key exclusion· 9
  • Severe hearing or speech impairment or other disability limiting participation
  • Resident in nursing home or long-term care facility at baseline
  • Current inpatient psychiatric hospitalization
  • Dementia diagnosis or active psychosis

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04545489
NCT04545489N/ACompleted

A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease Prevention (V-EXTRA-CVD)

VA Office of Research and Development·interventional·Posted Sep 11, 2020·Updated Oct 30, 2025

In Brief

A clinical study evaluating Intervention group and Education control group for Cardiovascular Disease and 3 related conditions. Completed, enrolled 305 participants across 4 sites.

Detailed Summary

The VA is the largest single provider of HIV care in the US and Veterans with HIV use significantly more healthcare services and have a 1.5-2x higher risk of atherosclerotic cardiovascular disease (ASCVD) compared to uninfected Veterans. The goal is to improve BP treatment for Veterans with HIV to reduce ASCVD risk. Within a randomized controlled trial (RCT), the investigators hypothesize that the VA adapted nurse-led intervention will result in a clinically significant 6 millimeters of mercury (mmHg) reduction in systolic blood pressure (SBP) over 12 months compared to those receiving enhanced education only. The study is innovative because of the use of stakeholder-engaged design process, multi-component nurse-led intervention, and VA Video Connect (VVC) to monitor CVD risk factors. The project meets VA strategic priorities including: 1) greater choice for Veterans; 2) improve timeliness of services; 3) focus more resources more efficiently (strengthen foundational services in VA). If shown to be effective, this intervention will have substantial impact among high-risk Veterans, potentially reducing ASCVD events by more than a quarter.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 11, 2020
Enrollment StartDec 1, 2020
Primary CompletionOct 1, 2024
Study CompletionMar 31, 2025
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 5.8 years ago

Interventions

Intervention groupbehavioral

This is a intervention for 12 months which focuses on behavioral and medication management, led by a health coach (nurse or pharmacist)

Education control groupbehavioral

This group will receive education materials related to CVD risk reduction at each 4 month visit over the course of 12 months.